Press Releases
ViiV Healthcare announces FDA approval to lower the weight limit for dolutegravir in children and adolescents living with HIV
ViiV Healthcare announced that the US FDA has approved a supplemental New Drug Application (sNDA) for dolutegravir 10mg and 25mg oral tablets, reducing the weight...
Press Releases
AstraZeneca enters commercialisation agreement with Aspen for anaesthetic medicines portfolio
Agreement expands commercial reach for anaesthetics and supports the Company’s sharp focus on innovative new medicines in its three main therapy areas. ...
Press Releases
PCI Pharma Services’ Hay-on-Wye Site Launches New 3D Camera Technology from Scanware
PCI Pharma Services is installing specialist, innovative three-dimensional (3D) and high resolution color camera technology for product inspection and fill control on three of its...
Press Releases
Janssen Phase 3 Data Severely Active Rheumatoid Arthritis Shows Sirukumab Significantly Inhibited Radiographic Progression and Improved Signs
Janssen Research & Development, LLC announced results from a pivotal Phase 3 study evaluating subcutaneous sirukumab (CNTO 136), a human anti-interleukin (IL)-6 monoclonal antibody in...
Press Releases
Pfizer Announces FDA Advisory Committees Recommend ALO-02 Extended-Release Capsules For Approval
Pfizer Inc. announced that the U.S. FDA Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee voted (9 to...
Press Releases
ALF 5000: New Filling and Closing Machine for Ampoules and Injection Bottles from Bosch
Increased performance and higher safety Output of up to 600 containers per minute Flexible use: compatible with all commonfilling systems ...
Press Releases
AstraZeneca,Ironwood enter U.S. licensing agreement for lesinurad
AstraZeneca announced that it has completed the licensing agreement with Ironwood Pharmaceuticals for the exclusive US rights to Zurampic (lesinurad) and the fixed-dose combination of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.